http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2340368-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e73b04a7e7fd17a778aa66face5e78b6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fadcd8b78dfffd87cff9ae920b3e2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6580cc7c87da8741194bb44ced9e6dad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92613af17b27b662bc7dd441b63c91ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92691d309da4db0cec082ce9986481d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0670a16060c4f639b1d0ab183dfd4d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4583bcae267ae024a3123b1bb82f742d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91e7581fd72ace0e4d58bc0475f55448 |
| publicationDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2340368-C1 |
| titleOfInvention | Method of treatment of ischemic disease |
| abstract | FIELD: medicine; physiotherapy. n SUBSTANCE: perform the course of the general magnetic therapy in amount of 10 procedures, daily. The first procedure - 10 minutes, the subsequent procedures - 20 minutes. Thus at carrying out of the general magnetic therapy consider an optimum dose of magnetic induction for the specific patient, selected for the chemiluminescent response activated in vitro blood phagocytes: at normoproductive cellular response - 0.5 mT, at hyperproductive - 0.75 mT, at hypoproductive - 1 mT. If necessary repeat the course in 2 months. n EFFECT: increase of efficiency of treatment of ischemic disease, at the expense of carrying out of a complex of medical-diagnostic actions on the basis of definition of individual indications for the concrete patient and also depression of risk of complications at treatment of serious forms of an ischemic heart disease. n 1 tbl, 3 ex |
| priorityDate | 2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.